This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
Pub: 2003 Epub: Authors Shiba T , Aiba Y , Ishikawa H , Ushiyama A , Takagi A , Mine T , Koga Y ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅ Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604
Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z ,
<i>Bifidobacterium infantis</i> Potentially Alleviates Shrimp Tropomyosin-Induced Allergy by Tolerogenic Dendritic Cell-Dependent Induction of Regulatory T Cells and Alterations in Gut Microbiota. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1536
Pub: 2017 Epub: 2017 Nov 10 Authors Fu L , Song J , Wang C , Fu S , Wang Y ,
<i>Bifidobacterium infantis</i> Potentially Alleviates Shrimp Tropomyosin-Induced Allergy by Tolerogenic Dendritic Cell-Dependent Induction of Regulatory T Cells and Alterations in Gut Microbiota. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1536
Pub: 2017 Epub: 2017 Nov 10 Authors Fu L , Song J , Wang C , Fu S , Wang Y ,
<i>Bifidobacterium infantis</i> Potentially Alleviates Shrimp Tropomyosin-Induced Allergy by Tolerogenic Dendritic Cell-Dependent Induction of Regulatory T Cells and Alterations in Gut Microbiota. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1536
Pub: 2017 Epub: 2017 Nov 10 Authors Fu L , Song J , Wang C , Fu S , Wang Y ,
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅ Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322
Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO ,
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅ Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322
Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO ,
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅ Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322
Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO ,
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅ Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322
Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO ,
Bifidobacteriumlongum subsp. infantis CECT7210 (B. infantis IM-1®) Displays In Vitro Activity against Some Intestinal Pathogens. ✅
Nutrients (Nutrients ) Vol: 12 Issue 11 Pages:
Pub: 2020 Oct 24 Epub: 2020 Oct 24 Authors Ruiz L , Flórez AB , Sánchez B , Moreno-Muñoz JA , Rodriguez-Palmero M , Jiménez J , Gavilán CGLR , Gueimonde M , Ruas-Madiedo P , Margolles A ,
Bifidobacteriumlongum subsp. infantis CECT7210 (B. infantis IM-1®) Displays In Vitro Activity against Some Intestinal Pathogens. ✅
Nutrients (Nutrients ) Vol: 12 Issue 11 Pages:
Pub: 2020 Oct 24 Epub: 2020 Oct 24 Authors Ruiz L , Flórez AB , Sánchez B , Moreno-Muñoz JA , Rodriguez-Palmero M , Jiménez J , Gavilán CGLR , Gueimonde M , Ruas-Madiedo P , Margolles A ,
The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment. ✅ Go to Publication ✅
Data in brief (Data Brief ) Vol: 19 Issue Pages: 1025-1029
Pub: 2018 Aug Epub: 2018 May 24 Authors Jena PK , Sheng L , Nagar N , Wu C , Barile D , Mills DA , Wan YY ,
[Bifidobacterium longum subsp. infantis CECT 7210 (B. infantis IM-1®) shows activity against intestinal pathogens]. ✅ Go to Publication ✅
Nutricion hospitalaria (Nutr Hosp ) Vol: 39 Issue Spec No3 Pages: 65-68
Pub: 2022 Sep 1 Epub: Authors Moreno-Muñoz JA , Martín-Palomas M , Jiménez López J ,
A Whey Fraction Rich in Immunoglobulin G Combined with Bifidobacterium longum subsp. infantis ATCC 15697 Exhibits Synergistic Effects against Campylobacter jejuni. ✅ Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 21 Issue 13 Pages:
Pub: 2020 Jun 29 Epub: 2020 Jun 29 Authors Quinn EM , Kilcoyne M , Walsh D , Joshi L , Hickey RM ,
Bifidobacterium longum subsp. infantis ATCC 15697 and Goat Milk Oligosaccharides Show Synergism In Vitro as Anti-Infectives against Campylobacter jejuni. ✅ Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 9 Issue 3 Pages:
Pub: 2020 Mar 17 Epub: 2020 Mar 17 Authors Quinn EM , Slattery H , Walsh D , Joshi L , Hickey RM ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅ Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832
Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749
Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K ,
A Probiotic Bacterium with Activity against the Most Frequent Bacteria and Viruses Causing Pediatric Diarrhea: Bifidobacterium longum subsp. infantis CECT 7210 (B. infantis IM1(®)). ✅ Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 6 Pages:
Pub: 2024 Jun 11 Epub: 2024 Jun 11 Authors Moreno-Muñoz JA , Ojeda JD , López JJ ,

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]